RHI
27
2
IPG
53
6
BMY
37
2
DVA
52
-2
DGX
46
3
UHS
43
-4
LOW
36
2
PEG
39
2
ALL
43
3
DG
40
-2
EQR
37
3
AMG
71
2
GS
76
13
IRM
31
3
FTI
61
-5
A
48
2
HRB
56
2
AEE
68
5
FOX
60
-2
ROST
52
2
RHI
27
2
IPG
53
6
BMY
37
2
DVA
52
-2
DGX
46
3
UHS
43
-4
LOW
36
2
PEG
39
2
ALL
43
3
DG
40
-2
EQR
37
3
AMG
71
2
GS
76
13
IRM
31
3
FTI
61
-5
A
48
2
HRB
56
2
AEE
68
5
FOX
60
-2
ROST
52
2
Financhill
Back

Nuveen AMT-Free Municipal Income Fund Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
20

NEA
Nuveen AMT-Free Municipal Income Fund

Last Price:
$10.74
Seasonality Move:
-1.69%
Sell
46

SRPT
Sarepta Therapeutics

Last Price:
$21.99
Seasonality Move:
29.39%
Sell
20
Nuveen AMT-Free Municipal Income Fund (NEA) is a Sell

Is Nuveen AMT-Free Municipal Income Fund a Buy, Sell or Hold?

  • The current Nuveen AMT-Free Municipal Income Fund [NEA] share price is $10.82. The Score for NEA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • NEA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
46
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $18.38. The Score for SRPT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NEA Stock Price Chart

What is Nuveen AMT-Free Municipal Income Fund's stock price today?

  • The Nuveen AMT-Free Municipal Income Fund share price today is $10.82
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NEA is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $18.38
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

NEA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.98 Buy
Relative Strength Index (14 RSI): 40.95 Sell
Chaikin Money Flow: -609756 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.82 - 10.98) Sell
Bollinger Bands (100): (10.72 - 11.28) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.08 Buy
Relative Strength Index (14 RSI): 31.79 Sell
Chaikin Money Flow: 7064730 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.71 - 28.77) Sell
Bollinger Bands (100): (25.12 - 81.7) Sell

NEA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.96 Sell
20-day SMA: 10.91 Sell
50-day SMA: 10.89 Sell
200-day SMA: 11.29 Sell
8-day EMA: 9.04 Buy
20-day EMA: 5.51 Buy
50-day EMA: 2.67 Buy
200-day EMA: 0.74 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.6 Sell
20-day SMA: 18.6 Sell
50-day SMA: 30.56 Sell
200-day SMA: 87.14 Sell
8-day EMA: 15.43 Buy
20-day EMA: 9.43 Buy
50-day EMA: 4.58 Buy
200-day EMA: 1.27 Buy

Nuveen AMT-Free Municipal Income Fund Earnings Growth & NEA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.77 per share, a decrease this year of $5.77 per share, and an increase next year of $5.30 per share.

Nuveen AMT-Free Municipal Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):